MARC C MEULENER

Allopathic & Osteopathic Physicians|Dermatology BASKING RIDGE, NJ NPI 1770739633

General Payments — all program years on this page

$1,032.44

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 64
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $234.05 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $234.0521

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $136.3114
NOVARTIS PHARMACEUTICALS CORPORATION $32.341
Amgen Inc. $28.662
MAYNE PHARMA COMMERCIAL LLC $20.803
Dermavant Sciences, Inc. $15.941

By program year

Program yearAmountRecords
2019 $138.926
2020 $15.141
2022 $221.857
2023 $422.4829
2024 $234.0521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087153664 Novartis Pharmaceuticals Corporation $32.34 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028263 ABBVIE INC. $11.03 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028265 ABBVIE INC. $21.32 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028267 ABBVIE INC. $10.80 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028269 ABBVIE INC. $11.82 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028271 ABBVIE INC. $20.48 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028273 ABBVIE INC. $3.32 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028275 ABBVIE INC. $11.57 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028277 ABBVIE INC. $2.54 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028279 ABBVIE INC. $10.52 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028281 ABBVIE INC. $5.37 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028283 ABBVIE INC. $4.34 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028285 ABBVIE INC. $5.30 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028287 ABBVIE INC. $5.35 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105028289 ABBVIE INC. $12.55 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117327535 Amgen Inc. $14.73 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117327537 Amgen Inc. $13.93 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127906517 Dermavant Sciences, Inc. $15.94 10/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154671955 MAYNE PHARMA COMMERCIAL LLC $6.42 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154671957 MAYNE PHARMA COMMERCIAL LLC $7.71 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154671959 MAYNE PHARMA COMMERCIAL LLC $6.67 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.